Andreas Bhagwani
Chief Executive Officer at NANOLOGICA AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eva Osterman | F | 53 |
Nanghavi AB
Nanghavi Cromatograpy Solutions Pvt Ltd.
Nanologica Yellow AB
Nanologica Black AB
| 7 years |
| Tore Bengtsson | M | - |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
| Johanna Johansson | F | - | - | |
| Sana Alajmovic | F | - |
Sigrid Therapeutics AB
 Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 10 years |
| Gisela Marie Sitbon | M | 66 | 12 years | |
| Roger Glen Berlin | M | 74 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 8 years |
| Tore Bengtsson | M | - |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 10 years |
| Mattias Bengtsson | M | 55 | 5 years | |
| Mattias Giovanni Fili | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 11 years |
| Robert Taflin | M | 55 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Vik 1:81 AB
| 11 years |
| Lena Margareta Torlegård | F | 61 | 10 years | |
| Anders Rabbe | M | 54 | 4 years | |
| Thomas Bengt Eldered | M | 64 | 3 years | |
| Mattias Ankarberg | M | 48 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | - |
| Maarten de Château | M | 61 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
| Kai Gerrit Björn Gruner | M | 59 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 7 years |
| Carita Jagenheim | F | - | - | |
| Sangwoo Lee | M | 52 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 5 years |
| Anders Olof Adolf Ekblom | M | 70 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 2 years |
| Carl-Johan Spak | M | 68 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
| Mats Georg Arnhög | M | 73 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | - |
| Alexandra Ekman Ryding | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 6 years |
| Ulf Arne Wiinberg | M | 66 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Kramar | M | 70 | 3 years | |
| Hans Lennernäs | M | 64 | - | |
| Mårten Steen | M | 48 | 2 years | |
| Eva Byrod | F | 72 | 6 years | |
| Åsa Inde | F | 64 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | - |
| Paula Zeilon | F | 62 | - | |
| Stina Elofsson | F | - | - | |
| Adam Feiler | M | 50 | - | |
| Nina Lanner | F | - | - | |
| Peter von Ehrenheim | M | 69 | 3 years | |
| Kia Bengtsson | F | - | - | |
| Anna-Karin Renström | F | 60 | 5 years | |
| Catharina Rydgård | F | 63 | - | |
| Gary Pitcairn | M | 57 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 37 | 100.00% |
| India | 1 | 2.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andreas Bhagwani
- Personal Network
